Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut

finance.yahoo.com/news/sixth-street-backed-caris-life-164623321.html

By Pritam Biswas and Niket Nishant
(Reuters) -Caris Life Sciences' shares jumped nearly 29% in their Nasdaq debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new listings in 2025.
The shares opened at $27…

This story appeared on finance.yahoo.com, 2025-06-18 16:46:23.
The Entire Business World on a Single Page. Free to Use →